Benzonatate Capsule
Product Images NDC 51655-754

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 51655-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 754 20 Master Bottle Label Approval Rev A 07 21)

Label (51655 754 20 Master Bottle Label Approval   Rev A 07 21)
Label for Benzonatate Capsules USP 100 mg, containing 20 capsules. The label notes it is a prescription drug, instructs storage at 20° - 25°C, and to keep out of reach of children. Packaged by Northwind Pharmaceuticals and labeled under Northwind Health Company, LLC.*
FDA Label Image

Structure Formula (Structure Formula)

Structure Formula (Structure Formula)
Chemical structure diagram of Benzonatate, showing its molecular formula as C30H53NO11 with detailed functional groups and bonds depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.